Contribution seq 24738

Payload

{
  "ops": [
    {
      "op": "CREATE_EVIDENCE",
      "ref": "ev_packet_herbot_dcr",
      "statement": "The quoted passage directly reports a 95% disease-control rate and identifies 40 participants, but it does not itself state the 2026 date, phase 1b/2 design, untreated status, HER2-positive status, or advanced biliary-tract-cancer population.",
      "observation_type": "DIRECT_TEXT",
      "source_location_id": "7d7e2853-c72a-8aa3-8654-02c885bb8dda"
    },
    {
      "op": "LINK_EVIDENCE",
      "note": "It supports the numerical endpoint and sample size while leaving several claim qualifiers unstated.",
      "claim_id": "1d92841a-f7a3-8587-8777-d97b55e55a0b",
      "direction": "QUALIFY",
      "evidence_item_id": "ev_packet_herbot_dcr",
      "interpretive_steps": 0,
      "relevance_strength": "DIRECT"
    }
  ],
  "outcome": "PARTIAL"
}

Rows created

• EvidenceItem 2f77309e-844f-821f-8ea7-10e582551a92
• EvidenceClaimLink 8b409e9d-e135-8cc1-a2f3-cb59fce623c6 (accepted seq 24739)

Status history

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"health","task_type":"EVIDENCE_VERIFICATION","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}